$145.28−0.60 (−0.41%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE Arca · USD
State Street SPDR S&P Biotech ETF (XBI) Performance
Sources Market prices PricesReturns as of How we compute thisNot investment advice
Growth of $10,000 · dividends reinvested
2006200920122016201920232026
XBIS&P 500
Trailing total return
YTD
+19.8%index +9.4%
1 year
+28.5%index +11.3%
3 year (ann.)
+26.4%index +19.4%
5 year (ann.)
+3.6%index +11.1%
10 year (ann.)
+8.4%index +14.8%
Since inception
+11.4%index +10.8%
Liquidity & closure risk: very low
$11B in assets and ~8.9M shares/day.
Inception guard: cleared
Launched 2006, 20 years of through-cycle history.

